0001209191-23-034642.txt : 20230605
0001209191-23-034642.hdr.sgml : 20230605
20230605192337
ACCESSION NUMBER: 0001209191-23-034642
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230605
DATE AS OF CHANGE: 20230605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leheny A. Rachel
CENTRAL INDEX KEY: 0001484729
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 23994474
MAIL ADDRESS:
STREET 1: C/O ANTHERA PHARMACEUTICALS, INC.
STREET 2: 25801 INDUSTRIAL BOULEVARD, SUITE B
CITY: HAYWARD
STATE: CA
ZIP: 94545
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CalciMedica, Inc.
CENTRAL INDEX KEY: 0001534133
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452120079
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-952-5500
MAIL ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: CalciMedica, Inc. /DE/
DATE OF NAME CHANGE: 20230322
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG VISION, INC.
DATE OF NAME CHANGE: 20170717
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG, Inc.
DATE OF NAME CHANGE: 20150303
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0407
4/A
2023-05-16
2023-05-18
0
0001534133
CalciMedica, Inc.
CALC
0001484729
Leheny A. Rachel
C/O CALCIMEDICA, INC.
505 COAST S. BLVD. #202
LA JOLLA
CA
92037
1
1
1
0
Chief Executive Officer
0
Common Stock
2023-05-16
4
P
0
1000
2.698
A
1000
I
By Spouse
The weighted average purchase price for the transaction reported was $2.698, and the range of prices were between $2.68 and $2.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
On May 18, 2023, the reporting person filed a Form 4 which inadvertently omitted the purchase of shares of the Issuer's Common Stock by her spouse which is reported in this amendment.
By John Dunn, Attorney-in-Fact
2023-06-05